RETRACTED: The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis (Retracted article. See vol. 80, pg. 1140, 2020)

被引:141
作者
Bischof, Oliver
Schwamborn, Klaus
Martin, Nadine
Werner, Andreas
Sustmann, Claudio
Grosschedl, Rudolf
Dejean, Anne [1 ]
机构
[1] Inst Pasteur, INSERM, Nucl Org & Oncogenesis Unit, U579, F-75724 Paris 15, France
[2] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany
关键词
D O I
10.1016/j.molcel.2006.05.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular senescence and apoptosis have evolved to restrain unwarranted proliferation of potentially tumorigenic cells. Here we show that overexpression of the E3 SUMO ligase PIASy in normal human fibroblasts recruits the p53 and Rb tumor suppressor pathways to provoke a senescence arrest. By contrast, in Rb-deficient fibroblasts, expression of PIASy leads to p53-dependent apoptosis. Induction of senescence requires PIASy E3 activity and is specific for this member of the PIAS ligase family. PIASy stimulates sumoylation and transcriptional activity of p53 and increases Rb-dependent corepression through recruitment to E2F-responsive promoters. Viral oncoprotein E6 suppresses both PIASy-induced senescence and sumoylation of PIASy substrates. Finally, we show that fibroblasts lacking PIASy exhibit a highly reduced propensity to undergo senescence in response to a prosenescence stimulus. Altogether, these data provide the first evidence for a direct role of an E3 SUMO ligase, and by implication of the SUMO pathway, in cellular senescence and apoptosis.
引用
收藏
页码:783 / 794
页数:12
相关论文
共 53 条
  • [1] DEFICIENCY OF RETINOBLASTOMA PROTEIN LEADS TO INAPPROPRIATE S-PHASE ENTRY, ACTIVATION OF E2F-RESPONSIVE GENES, AND APOPTOSIS
    ALMASAN, A
    YIN, YX
    KELLY, RE
    LEE, EYHP
    BRADLEY, A
    LI, WW
    BERTINO, JR
    WAHL, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5436 - 5440
  • [2] Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation
    Ayyanathan, K
    Lechner, MS
    Bell, P
    Maul, GG
    Schultz, DC
    Yamada, Y
    Tanaka, K
    Torigoe, K
    Rauscher, FJ
    [J]. GENES & DEVELOPMENT, 2003, 17 (15) : 1855 - 1869
  • [3] RETRACTED: Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways (Retracted Article)
    Bischof, O
    Nacerddine, K
    Dejean, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (03) : 1013 - 1024
  • [4] Regulation and localization of the Bloom syndrome protein in response to DNA damage
    Bischof, O
    Kim, SH
    Irving, J
    Beresten, S
    Ellis, NA
    Campisi, J
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 153 (02) : 367 - 380
  • [5] Gam1 and the SUMO pathway
    Boggio, R
    Chiocca, S
    [J]. CELL CYCLE, 2005, 4 (04) : 533 - 535
  • [6] Cellular senescence as a tumor-suppressor mechanism
    Campisi, J
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (11) : S27 - S31
  • [7] DEGRADATION OF P53 CAN BE TARGETED BY HPV E6 SEQUENCES DISTINCT FROM THOSE REQUIRED FOR P53 BINDING AND TRANSACTIVATION
    CROOK, T
    TIDY, JA
    VOUSDEN, KH
    [J]. CELL, 1991, 67 (03) : 547 - 556
  • [8] DAVIDSSON P, 2002, INT J ENTREPRENEURSH, V1, P1
  • [9] Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor
    Dimri, GP
    Itahana, K
    Acosta, M
    Campisi, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) : 273 - 285
  • [10] What has senescence got to do with cancer?
    Dimri, GP
    [J]. CANCER CELL, 2005, 7 (06) : 505 - 512